Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | POLB | P06746 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | EGFR | P00533 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | RAD52 | P43351 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | NSD2 | O96028 | 2/20 | 0.57 |
| ▸ | FGB | P02675 | 1/20 | 0.57 |
| ▸ | MMP14 | P50281 | 1/20 | 0.57 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31616803 | 0.99 | KMT2A (0.61) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL15859645 | 0.96 | NSD2 (0.61) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL8426997 | 0.90 | TOP2B (0.64) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL27294872 | 0.89 | TOP2B (0.62) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL20334294 | 0.87 | NSD2 (0.52) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL4732627 | 0.85 | MEN1 (0.72) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL20334359 | 0.84 | TOP2B (0.57) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL8429091 | 0.84 | TOP2B (0.57) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL6678121 | 0.82 | MAPT (0.77) | KMT2AMEN1MAPTPOLBALDH1A1 | |
| SCHEMBL32679354 | 0.82 | MAPT (0.77) | KMT2AMEN1MAPTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5948268-A | DISSOLVING IN WATER TO BE TREATED A POLYMER FORMED FROM WATER SOLUBLE MONOMER UNITS COMPRISING A (POLY)ALKYLENE OXIDE END CAPPED WITH AN ADDITION POLYMERIZABLE GROUP AT ONE END AND AN INTENSELY FLUORESCENT GROUP AT OTHER | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-09-07 | — | — | US | claimed |
| US-11378546-B2 | PH Meter | PARKER HANNIFIN CORP (US) | 2022-07-05 | — | — | US | disclosed |
| EP-3734264-A1 | PH METER | Parker Hannifin Corporation (US) | 2020-11-04 | — | — | EP | disclosed |
| US-20200064307-A1 | pH METER | PARKER HANNIFIN CORP (US) | 2020-02-27 | — | — | US | disclosed |
| US-20150346144-A1 | PH METER | PARKER-HANNIFIN CORPORATION | 2015-12-03 | — | — | US | disclosed |
| US-20150346144-A1 | PH METER | PARKER-HANNIFIN CORPORATION | 2015-12-03 | — | — | US | disclosed |
| WO-2014106066-A1 | PH METER | SENOVA SYSTEMS, INC. (US) | 2014-07-03 | — | — | WO | disclosed |
| US-20030203975-A1 | Anti-cancer agents | BTG INTERNATIONAL LIMITED (GB) | 2003-10-30 | — | — | US | disclosed |
| EP-0761604-B1 | An agent for water treatment | NIPPON CATALYTIC CHEM IND (JP) | 2000-06-14 | — | — | EP | disclosed |
| US-5948268-A | DISSOLVING IN WATER TO BE TREATED A POLYMER FORMED FROM WATER SOLUBLE MONOMER UNITS COMPRISING A (POLY)ALKYLENE OXIDE END CAPPED WITH AN ADDITION POLYMERIZABLE GROUP AT ONE END AND AN INTENSELY FLUORESCENT GROUP AT OTHER | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0761604-A2 | An agent for water treatment | NIPPON SHOKUBAI CO., LTD. (JP) | 1997-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203975-A1 | Anti-cancer agents | TOP2B, TOP2A, TOP1 | KMT2A 3724/4885MEN1 3787/4885MAPT 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.